A PI3K inhibitor (LY294002) reduced EXD-mediated protection of cell death and apoptosis (Figure 4), in accordance with the previous reports that activation of PI3K-Akt pathway attenuates osteoblast injury in osteoporosis (Vanella et al., 2010). The gene discussed is AKT1; the disease is osteoporosis.